Drosmark 20 is a low dose combined oral contraceptive (COC) tablet. Each tablet consists of Ethinylestradiol 0.02 mg and Drospirenone 3 mg which is a clinically proven combination. It provides effective contraception with additional therapeutic advantages. This is specifically useful for women who have hormone sensitive symptoms such acne and premenstrual discomfort.
The formulation has an ultra low dose of Ethinylestradiol (0.02 mg) which makes it one of the lowest oestrogen combined pill options available. This low oestrogen content is developed to reduce oestrogen related side effects while managing excellent contraceptive efficiency when taken appropriately. Drospirenone (3 mg) is a fourth generation progestogen with an exceptional pharmacological profile. It has an anti-mineralcorticoid and anti-androgenic properties that stands out from older progestogens.
The antimineralocorticoid activity of Drospirenone counteracts the fluid retaining impact of oestrogen which can help minimise cyclical weight gain and water retention that a few women experience with other oral contraceptives. Its anti androgenic activity makes Drosmark 20 specifically fit for women who are suffering from androgen mediated situations such as seborrhea and hirsutism providing a meaningful improvement in skin quality and contraceptive protection.
Mechanism of Action
Drosmark-20 exerts its contraceptive effect through three complementary mechanisms:
Suppression of ovulation: The combined oestrogen and progestogen component inhibits the hypothalamic-pituitary-ovarian axis, preventing the mid-cycle LH surge responsible for ovulation.
Cervical mucus thickening: Drospirenone alters the consistency of cervical mucus, making it hostile to sperm penetration and reducing the likelihood of fertilisation.
Endometrial modification: The tablet creates an unfavourable endometrial environment, reducing the possibility of implantation should ovulation occur.
Key Clinical Benefits
Low Oestrogen Load
At only 0.02 mg Ethinylestradiol, Drosmark-20 carries a lower risk of oestrogen-related side effects including nausea, breast tenderness, and headache compared to standard-dose formulations.
Anti-androgenic Action
Drospirenone’s anti-androgenic property reduces sebum production and helps clear acne, making Drosmark-20 a preferred choice for women with hormonally driven skin concerns.
Anti-mineralocorticoid Effect
Counteracts oestrogen-related fluid retention, reducing bloating and cyclical weight fluctuations that commonly deter adherence to oral contraception.
Cycle Control
The 24-tablet active + 4-tablet hormone-free interval (24/4 regimen in the standard blister) maintains excellent cycle control with reduced hormone-free interval symptoms.
WHO-GMP Manufactured
Produced in WHO-GMP certified facilities by Aunexis Pharmaceuticals, ensuring consistent quality, purity, and safety across every blister.
Dosage & Administration
One tablet daily, taken orally at approximately the same time each day for 28 consecutive days as directed by the prescribing physician. Tablets should be swallowed whole with water and may be taken with or without food.
Contraindications
Drosmark-20 is contraindicated in patients with:
- Known or suspected pregnancy
- History of or current thromboembolic disorders (DVT, pulmonary embolism)
- History of stroke or ischaemic heart disease
- Uncontrolled hypertension
- Severe hepatic impairment or hepatic tumours
- Hormone-dependent malignancies (e.g. breast cancer, endometrial cancer)
- Hyperkalaemia or conditions predisposing to high potassium levels
- Hypersensitivity to Ethinylestradiol, Drospirenone, or any excipient
- Active migraine with aura
FAQs
What is Drosmark-20 used for?
Drosmark-20 is used for contraception, acne management, relief of premenstrual symptoms, dysmenorrhoea, and regulation of menstrual cycles in women of reproductive age.
What is the composition of Drosmark-20?
Each tablet contains Ethinylestradiol 0.02 mg and Drospirenone 3 mg, combining a low-dose synthetic oestrogen with a fourth-generation anti-androgenic progestogen.
How does Drosmark-20 prevent pregnancy?
It suppresses ovulation, thickens cervical mucus to block sperm, and modifies the endometrium to create an unfavourable environment for implantation.
What makes Drosmark-20 different from other combined pills?
Its ultra-low oestrogen dose (0.02 mg) and Drospirenone’s anti-androgenic and anti-mineralocorticoid properties reduce side effects like bloating, acne, and fluid retention.
Can Drosmark-20 help with acne?
Yes. Drospirenone’s anti-androgenic action reduces sebum production, helping to manage hormonal acne in women prescribed this tablet by their physician.
Does Drosmark-20 cause weight gain?
Unlike many older progestogens, Drospirenone counteracts oestrogen-related fluid retention, which may reduce cyclical bloating and weight fluctuation in some patients.
